Stock listing
KRX:053030 Binex Co., Ltd (바이넥스) 주가
Follow Binex Co., Ltd into a list and get an email when it puts out news.
Share price · KRX:053030
₩7,000.00 KRW +150.00 (+2.2%)
Close on Nov 20, 2026
- Day range
- ₩6,780.00 – ₩7,180.00 KRWNov 20, 2026
- Volume
- 103,776 sharesNov 20, 2026
- Market cap
- ₩218.3B KRWAt the close on Nov 20, 2026 · price × 31.19M shares outstanding
- 52-week range
- ₩5,500.00 – ₩16,800.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩603.4M KRWMedian day 59,393 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:053030 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩7,000.00 | +150.00 | +2.2% | ₩6,810.00 | ₩7,180.00 | ₩6,780.00 | 103,776 | |
| ₩6,850.00 | +50.00 | +0.7% | ₩6,890.00 | ₩6,890.00 | ₩6,700.00 | 104,742 | |
| ₩6,800.00 | +120.00 | +1.8% | ₩6,650.00 | ₩7,000.00 | ₩6,560.00 | 181,039 | |
| ₩6,680.00 | +290.00 | +4.5% | ₩6,630.00 | ₩6,860.00 | ₩6,390.00 | 143,958 | |
| ₩6,390.00 | +30.00 | +0.5% | ₩6,310.00 | ₩6,780.00 | ₩6,310.00 | 146,314 | |
| ₩6,360.00 | -380.00 | -5.6% | ₩6,600.00 | ₩6,630.00 | ₩6,290.00 | 120,815 | |
| ₩6,740.00 | +410.00 | +6.5% | ₩6,560.00 | ₩6,870.00 | ₩6,500.00 | 295,448 | |
| ₩6,330.00 | +190.00 | +3.1% | ₩6,220.00 | ₩6,460.00 | ₩6,150.00 | 135,329 | |
| ₩6,140.00 | +230.00 | +3.9% | ₩6,600.00 | ₩6,600.00 | ₩6,080.00 | 527,111 | |
| ₩5,910.00 | -250.00 | -4.1% | ₩5,800.00 | ₩6,020.00 | ₩5,710.00 | 55,330 | |
| ₩6,160.00 | +160.00 | +2.7% | ₩6,100.00 | ₩6,300.00 | ₩6,010.00 | 83,131 | |
| ₩6,000.00 | +160.00 | +2.7% | ₩5,890.00 | ₩6,090.00 | ₩5,690.00 | 82,405 | |
| ₩5,840.00 | -120.00 | -2.0% | ₩5,900.00 | ₩6,040.00 | ₩5,800.00 | 46,873 | |
| ₩5,960.00 | -70.00 | -1.2% | ₩5,850.00 | ₩6,060.00 | ₩5,850.00 | 23,840 | |
| ₩6,030.00 | -50.00 | -0.8% | ₩6,040.00 | ₩6,140.00 | ₩5,940.00 | 68,140 | |
| ₩6,080.00 | -20.00 | -0.3% | ₩6,110.00 | ₩6,120.00 | ₩5,960.00 | 50,222 | |
| ₩6,100.00 | +30.00 | +0.5% | ₩6,090.00 | ₩6,210.00 | ₩6,040.00 | 57,324 | |
| ₩6,070.00 | -140.00 | -2.3% | ₩6,230.00 | ₩6,300.00 | ₩6,050.00 | 71,691 | |
| ₩6,210.00 | +30.00 | +0.5% | ₩6,420.00 | ₩6,590.00 | ₩6,180.00 | 295,098 | |
| ₩6,180.00 | +60.00 | +1.0% | ₩5,970.00 | ₩6,200.00 | ₩5,960.00 | 44,606 | |
| ₩6,120.00 | +20.00 | +0.3% | ₩6,090.00 | ₩6,480.00 | ₩6,000.00 | 46,440 | |
| ₩6,100.00 | -20.00 | -0.3% | ₩6,120.00 | ₩6,250.00 | ₩6,040.00 | 59,468 | |
| ₩6,120.00 | -90.00 | -1.4% | ₩6,130.00 | ₩6,330.00 | ₩6,030.00 | 30,638 | |
| ₩6,210.00 | +110.00 | +1.8% | ₩5,950.00 | ₩6,230.00 | ₩5,950.00 | 37,255 | |
| ₩6,100.00 | +360.00 | +6.3% | ₩5,780.00 | ₩6,170.00 | ₩5,780.00 | 84,769 | |
| ₩5,740.00 | -220.00 | -3.7% | ₩5,740.00 | ₩5,840.00 | ₩5,600.00 | 124,045 | |
| ₩5,960.00 | -50.00 | -0.8% | ₩6,030.00 | ₩6,200.00 | ₩5,900.00 | 47,257 | |
| ₩6,010.00 | -60.00 | -1.0% | ₩6,030.00 | ₩6,040.00 | ₩5,800.00 | 91,282 | |
| ₩6,070.00 | -270.00 | -4.3% | ₩6,400.00 | ₩6,440.00 | ₩6,060.00 | 84,695 | |
| ₩6,340.00 | -170.00 | -2.6% | ₩6,450.00 | ₩6,560.00 | ₩6,340.00 | 46,133 | |
| ₩6,510.00 | -100.00 | -1.5% | ₩6,630.00 | ₩6,750.00 | ₩6,510.00 | 33,953 | |
| ₩6,610.00 | +200.00 | +3.1% | ₩6,430.00 | ₩6,680.00 | ₩6,430.00 | 51,788 | |
| ₩6,410.00 | -80.00 | -1.2% | ₩6,530.00 | ₩6,590.00 | ₩6,400.00 | 43,273 | |
| ₩6,490.00 | +260.00 | +4.2% | ₩6,180.00 | ₩6,500.00 | ₩6,160.00 | 59,318 | |
| ₩6,230.00 | +20.00 | +0.3% | ₩6,250.00 | ₩6,320.00 | ₩6,150.00 | 34,044 | |
| ₩6,210.00 | -170.00 | -2.7% | ₩6,320.00 | ₩6,350.00 | ₩6,130.00 | 73,403 | |
| ₩6,380.00 | +320.00 | +5.3% | ₩6,150.00 | ₩6,420.00 | ₩6,070.00 | 112,467 | |
| ₩6,060.00 | +60.00 | +1.0% | ₩6,080.00 | ₩6,100.00 | ₩5,990.00 | 34,488 | |
| ₩6,000.00 | -140.00 | -2.3% | ₩6,120.00 | ₩6,230.00 | ₩5,990.00 | 88,561 | |
| ₩6,140.00 | +150.00 | +2.5% | ₩6,090.00 | ₩6,210.00 | ₩6,090.00 | 52,841 | |
| ₩5,990.00 | -270.00 | -4.3% | ₩6,320.00 | ₩6,340.00 | ₩5,990.00 | 141,434 | |
| ₩6,260.00 | -80.00 | -1.3% | ₩6,390.00 | ₩6,390.00 | ₩6,230.00 | 37,859 | |
| ₩6,340.00 | -40.00 | -0.6% | ₩6,310.00 | ₩6,390.00 | ₩6,260.00 | 48,026 | |
| ₩6,380.00 | -70.00 | -1.1% | ₩6,410.00 | ₩6,570.00 | ₩6,320.00 | 45,318 | |
| ₩6,450.00 | -120.00 | -1.8% | ₩6,560.00 | ₩6,560.00 | ₩6,410.00 | 44,347 | |
| ₩6,570.00 | +50.00 | +0.8% | ₩6,460.00 | ₩6,590.00 | ₩6,450.00 | 30,910 | |
| ₩6,520.00 | -150.00 | -2.2% | ₩6,620.00 | ₩6,710.00 | ₩6,470.00 | 96,909 | |
| ₩6,670.00 | -90.00 | -1.3% | ₩6,700.00 | ₩6,790.00 | ₩6,650.00 | 58,337 | |
| ₩6,760.00 | -40.00 | -0.6% | ₩6,780.00 | ₩6,930.00 | ₩6,720.00 | 32,972 | |
| ₩6,800.00 | +20.00 | +0.3% | ₩6,920.00 | ₩6,920.00 | ₩6,740.00 | 33,601 | |
| ₩6,780.00 | +80.00 | +1.2% | ₩6,730.00 | ₩6,920.00 | ₩6,590.00 | 64,374 | |
| ₩6,700.00 | -210.00 | -3.0% | ₩7,000.00 | ₩7,050.00 | ₩6,650.00 | 52,876 | |
| ₩6,910.00 | -230.00 | -3.2% | ₩7,080.00 | ₩7,200.00 | ₩6,910.00 | 41,476 | |
| ₩7,140.00 | +160.00 | +2.3% | ₩7,000.00 | ₩7,280.00 | ₩6,920.00 | 46,885 | |
| ₩6,980.00 | -90.00 | -1.3% | ₩6,900.00 | ₩7,300.00 | ₩6,770.00 | 50,418 | |
| ₩7,070.00 | +40.00 | +0.6% | ₩7,090.00 | ₩7,150.00 | ₩6,900.00 | 40,539 | |
| ₩7,030.00 | -250.00 | -3.4% | ₩7,210.00 | ₩7,240.00 | ₩6,990.00 | 69,356 | |
| ₩7,280.00 | +230.00 | +3.3% | ₩7,150.00 | ₩7,300.00 | ₩7,090.00 | 93,786 | |
| ₩7,050.00 | -70.00 | -1.0% | ₩7,000.00 | ₩7,100.00 | ₩6,730.00 | 75,643 | |
| ₩7,120.00 | +450.00 | +6.7% | ₩6,840.00 | ₩7,140.00 | ₩6,770.00 | 110,534 | |
| ₩6,670.00 | -420.00 | -5.9% | ₩6,850.00 | ₩6,890.00 | ₩6,550.00 | 135,755 | |
| ₩7,090.00 | +520.00 | +7.9% | ₩7,530.00 | ₩7,530.00 | ₩6,820.00 | 554,852 |
Splits
3 splits since 2005 · KRX:053030 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 2-for-1 | Split | |
| 21-for-19 | Split | |
| 1.0717-for-1 | Split |
- Ticker
- KRX:053030
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- KRX
- Currency
- KRW
Binex Co., Ltd on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
Valuation
EV/sales 1.6× against a median of 4.3×: 3rd lowest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩245.2B KRW
- P/E
- Loss
- EV/sales
- 1.6×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 1.4×
- Gross margin
- 16.9%
- Operating margin
- −15.4%
- Net margin
- −18.6%
- Debt to equity
- 0.4×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Binex Co., Ltd · KRX:053030 | US$162.2M | US$182.2M | n/a | 1.6× | n/a | 1.4× | −18.6% | 0.4× | n/a |
| Dishman Carbogen Amcis Ltd. · NSE:DCAL | US$195.5M | US$195.5M | 26.6× | 0.8× | 4.2× | 0.3× | 3.0% | 0.0× | n/a |
| Quantum-Si Incorporated · NASDAQ:QSI | US$180.8M | US$80.11M | n/a | 63.3× | n/a | 1.1× | n/a | 0.0× | 3.19 |
| Tarsons Products Limited · NSE:TARSONS | US$174.2M | US$174.2M | 146× | 3.7× | 13.5× | 2.5× | 2.5% | 0.0× | n/a |
| AVE Science & Technology Co., Ltd. Class A · SSE:688067 | US$170.2M | US$138.2M | 33.8× | 3.9× | n/a | 2.1× | 14.3% | 0.0× | n/a |
| Boditech Med, Inc. · KRX:206640 | US$152.0M | US$120.9M | 7.9× | 0.9× | 4.4× | 0.8× | 14.8% | 0.0× | n/a |
| Genovis AB · OMXSTO:GENO | US$150.3M | US$142.9M | 74.9× | 10.8× | 41.7× | 5.0× | 15.1% | 0.3× | n/a |
| Genomictree, Inc. · KRX:228760 | US$147.7M | US$88.88M | n/a | 40.6× | n/a | 1.6× | −306.4% | 0.0× | n/a |
| Anbio Biotechnology · NASDAQ:NNNN | US$145.7M | US$133.8M | 22.8× | 15.5× | n/a | 4.8× | 74.1% | 0.0× | 0.56 |
| MaxCyte, Inc. · NASDAQ:MXCT | US$141.5M | US$57.06M | n/a | 1.7× | n/a | 0.9× | −81.4% | 0.1× | 0.93 |
| Shanghai Rightongene Biotechnology Co. Ltd. Class A · SSE:688217 | US$139.3M | US$102.6M | n/a | 4.6× | n/a | 1.1× | −43.9% | 0.0× | n/a |
| Median of the others | US$151.1M | US$127.4M | 30.1× | 4.3× | 9.0× | 1.4× | 3.0% | 0.0× | 0.93 |
Forecasts
Analysts' consensus from EODHD, read Nov 17, 2026. Not 6ix's view and not investment advice.
- Price target
- 9800.00 KRW · Analysts' mean
- EPS, year to Dec 2026
- -385.61 · 2 analysts
- Revenue, year to Dec 2026
- 166.6B · 2 analysts
Events
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 13, 2026 | +5.0% |
| Q2 2026 | Aug 14, 2026 · Before open | −1.1% |
| Q1 2026 | May 15, 2026 · Before open | 0.0% |
| Q4 2025 | Mar 13, 2026 · Before open | −0.9% |
| Q3 2025 | Nov 14, 2025 · Before open | −1.0% |
| Q2 2025 | Aug 14, 2025 · Before open | −0.4% |
| Q1 2025 | May 15, 2025 · Before open | +10.8% |
| Q4 2024 | Mar 14, 2025 · Before open | +6.3% |
| Q3 2024 | Nov 14, 2024 · Before open | −2.5% |
| Q2 2024 | Aug 14, 2024 · Before open | −1.2% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 14, 2024 · After close | +3.0% |
| Q4 2023 | Mar 15, 2024 · After close | +7.8% |
| Q3 2023 | Nov 14, 2023 · After close | +1.9% |
| Q2 2023 | Aug 11, 2023 · After close | −8.2% |
| Q1 2023 | May 9, 2023 · After close | −1.9% |
| Q4 2022 | Mar 2, 2023 | +1.1% |
| Q3 2022 | Nov 13, 2022 · After close | −0.9% |
| Q2 2022 | Aug 15, 2022 · After close | +1.0% |
| Q1 2022 | May 13, 2022 · Before open | +1.1% |
| Q4 2021 | Mar 2, 2022 · After close | +8.1% |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 168.5B | 130.1B | 154.8B | 156.7B | 134.4B | 133.0B | 125.3B | 104.0B | 78.0B | 80.9B |
| Cost of revenue | 123.4B | 108.8B | 97.9B | 86.2B | 74.4B | 69.9B | 68.5B | 55.8B | 49.6B | 51.8B |
| Gross profit | 45.1B | 21.3B | 56.9B | 70.5B | 60.0B | 63.0B | 56.8B | 48.2B | 28.4B | 29.1B |
| Research and development | 1.16B | 1.20B | 1.31B | 1.62B | 384.0M | 1.10B | 1.04B | 894.6M | 622.1M | 817.8M |
| Selling, general and administrative | 35.0B | 50.5B | 54.3B | 51.4B | 45.9B | 45.1B | 43.7B | 39.8B | 34.6B | 29.5B |
| Operating income | -4.53B | -30.8B | 3.37B | 17.2B | 13.2B | 16.1B | 11.3B | 6.88B | -8.70B | -2.77B |
| Depreciation and amortization | 13.9B | 8.74B | 7.24B | 5.99B | 6.00B | 5.68B | 9.06B | 8.98B | 8.98B | 3.89B |
| EBITDA | 9.36B | -22.0B | 10.6B | 23.2B | 19.2B | 21.8B | 20.3B | 15.9B | 285.1M | 1.12B |
| Interest expense | 4.45B | 2.30B | 1.97B | 2.06B | 1.69B | 1.44B | 2.12B | 0 | 0 | 0 |
| Income before tax | -5.70B | -38.9B | 4.89B | 15.2B | 24.2B | 6.21B | 10.6B | 4.80B | -11.8B | -3.70B |
| Income tax | 5.20B | -143.9M | 2.24B | -1.39B | -731.2M | -621.4M | ||||
| Net income | -3.23B | -35.1B | 4.67B | 12.4B | 19.1B | 6.41B | 8.50B | 6.34B | -11.3B | -3.00B |
| Earnings per share, basic | -101.29 | -1,134.08 | 151.04 | 402.42 | 617.44 | 205.53 | 272.67 | 203.26 | -367.25 | -97.73 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 18.4B | 25.7B | 8.16B | 3.34M | 2.14M | 50.6B | 18.5B | 13.1B | 11.3B | 6.16B |
| Short-term investments | 1.25B | 2.05B | 5.29B | 7.06B | 3.39B | 16.1B | 6.02B | 7.56B | 8.50B | 813.8M |
| Receivables | 22.2B | 16.4B | 14.2B | 22.1B | 17.3B | 24.3B | 18.9B | 18.8B | 21.7B | 29.6B |
| Inventory | 40.0B | 31.0B | 28.3B | 29.1B | 22.9B | 17.8B | 14.8B | 12.5B | 10.6B | 9.51B |
| Current assets | 112.9B | 92.6B | 73.7B | 109.0B | 108.3B | 118.7B | 73.8B | 59.3B | 54.1B | 48.4B |
| Property, plant and equipment | 132.5B | 128.8B | 121.8B | 101.2B | 93.8B | 92.6B | 88.7B | 91.1B | 93.9B | |
| Total assets | 311.4B | 279.4B | 257.0B | 298.4B | 272.5B | 270.1B | 202.8B | 190.4B | 167.8B | 177.1B |
| Accounts payable | 4.39B | 4.93B | 1.77B | 3.54B | 3.65B | 2.31B | 3.47B | 1.43B | 1.84B | 1.56B |
| Current liabilities | 62.7B | 92.2B | 67.4B | 98.3B | 32.7B | 27.0B | 37.8B | 37.3B | 32.1B | 25.2B |
| Long-term debt | 56.7B | 0 | 0 | 0 | 43.6B | 44.5B | 0 | 0 | 3.00B | 8.35B |
| Total debt | 56.6B | 23.4B | 3.00B | 35.0B | ||||||
| Total liabilities | 124.0B | 97.8B | 75.7B | 106.8B | 92.1B | 96.9B | 42.3B | 41.0B | 39.0B | 36.6B |
| Shareholders' equity | 187.3B | 181.4B | 181.3B | 191.6B | 180.4B | 173.2B | 160.5B | 149.4B | 128.8B | 140.5B |
| Shares outstanding | 31.8M | 30.9M | 30.9M | 30.9M | 30.9M | 31.2M | 31.2M | 31.2M | 30.8M | 30.7M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -23.3B | -9.43B | 3.78B | 17.1B | 28.1B | 19.9B | 10.8B | 13.6B | 8.14B | 3.80B |
| Capital spending | -23.3B | -11.4B | -16.2B | -36.5B | -11.8B | -7.70B | -8.79B | -2.55B | -2.27B | -5.34B |
| Free cash flow | -46.5B | -20.8B | -12.4B | -19.4B | 8.28B | 10.4B | 1.99B | 11.0B | 5.87B | -1.54B |
| Cash from investing | -2.85B | -14.2B | -39.1B | -13.8B | -28.2B | -2.42B | -14.1B | -4.34B | -12.3B | |
| Cash from financing | 29.8B | -12.6B | 3.22B | -14.8B | 40.8B | -2.95B | 2.32B | 1.07B | 2.77B | |
| Share buybacks | -5.32B | 211.3M | 54.0M | 5.32B | 54.0M | -1.07B | ||||
| Change in cash | -7.38B | 17.6B | -23.0B | -18.9B | -500.6M | 32.1B | 5.38B | 1.82B | 4.82B | -5.64B |
Cap table
Built by 6ix from Binex Co., Ltd’s releases
- Common shares
- 31,187,800
- Fully diluted
- 31,187,800
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 31,187,800 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 31,187,800 |
Log in to ask 6ix AI your own questions about Binex Co., Ltd.